Antifibrotics in rheumatoid arthritis-associated interstitial lung disease - real-world data from a nationwide cohort
{{output}}
Introduction: Interstitial lung disease (ILD) is the most common pulmonary manifestation of rheumatoid arthritis (RA) and is associated with an increased mortality. Clinical trials have shown that antifibrotics (nintedanib and pi... ...
